BillionToOne, Inc. (BLLN)
NASDAQ: BLLN · Real-Time Price · USD
85.94
-1.65 (-1.88%)
At close: Jan 9, 2026, 4:00 PM EST
87.65
+1.71 (1.99%)
After-hours: Jan 9, 2026, 6:47 PM EST
BillionToOne Revenue
BillionToOne had revenue of $83.52M in the quarter ending September 30, 2025, with 141.79% growth. This brings the company's revenue in the last twelve months to $254.14M. In the year 2024, BillionToOne had annual revenue of $152.58M with 112.72% growth.
Revenue (ttm)
$254.14M
Revenue Growth
+112.72%
P/S Ratio
3.49
Revenue / Employee
$409,897
Employees
620
Market Cap
3.93B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 152.58M | 80.85M | 112.72% |
| Dec 31, 2023 | 71.73M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBLLN News
- 5 days ago - BillionToOne Announces Selection of Northstar Select® as the new liquid biopsy test for LC-SCRUM-TRY clinical study at National Cancer Center Hospital East - PRNewsWire
- 19 days ago - BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 weeks ago - BillionToOne, Inc. (BLLN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - BillionToOne Appoints Anthony Pagano to Board of Directors as Audit Committee Chair - PRNewsWire
- 4 weeks ago - BillionToOne Reports Third Quarter 2025 Results - GlobeNewsWire
- 5 weeks ago - BillionToOne to Report Third Quarter 2025 Financial Results on December 9, 2025 - GlobeNewsWire
- 5 weeks ago - Analysts See Big Upside For Newly Listed Molecular Diagnostic Firm BillionToOne After Standout IPO Rally - Benzinga
- 5 weeks ago - BillionToOne wins upbeat coverage as analysts flag growth in prenatal, cancer tests - Reuters